We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
-1.28%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.01B
AUM Growth
-$305M
Cap. Flow
-$271M
Cap. Flow %
-26.9%
Top 10 Hldgs %
33.13%
Holding
2,245
New
779
Increased
227
Reduced
205
Closed
1,018

Sector Composition

Rank Sector Weight
1 Communication Services 18%
2 Financials 17.42%
3 Technology 16.14%
4 Industrials 6.99%
5 Healthcare 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMK
1076
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$13K ﹤0.01%
+18,719
New +$23.9K
CZOO
1077
DELISTED
Cazoo Group Ltd
CZOO
$13K ﹤0.01%
+233
New +$26.9K
AIM
1078
AIM ImmunoTech
AIM
$7.06M
$13K ﹤0.01%
+291
New +$17.9K
AQMS icon
1079
Aqua Metals
AQMS
$9.38M
$12K ﹤0.01%
52
-280
-84% -$67K
KZIA
1080
Kazia Therapeutics
KZIA
$159M
$12K ﹤0.01%
+233
New +$11.4K
NUTX
1081
Nutex Health
NUTX
$1.14B
$12K ﹤0.01%
+400
New +$19.3K
SATL icon
1082
Satellogic
SATL
$884M
$12K ﹤0.01%
+10,114
New +$17K
STRM
1083
DELISTED
Streamline Health Solutions
STRM
$12K ﹤0.01%
+826
New +$14.3K
UAVS icon
1084
AgEagle Aerial Systems
UAVS
$58.3M
$12K ﹤0.01%
74
+25
+51% +$5.15K
RDGT
1085
Ridgetech Inc
RDGT
$3.33M
$12K ﹤0.01%
17
-25
-60% -$24.9K
AMZE
1086
Amaze Holdings
AMZE
$1.57M
$12K ﹤0.01%
+155
New +$12.8K
NGM
1087
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$12K ﹤0.01%
+10,754
New +$22.3K
ARAV
1088
DELISTED
Aravive, Inc. Common Stock
ARAV
$12K ﹤0.01%
+90,076
New +$56.6K
ARVL
1089
DELISTED
Arrival Ordinary Shares
ARVL
$12K ﹤0.01%
10,295
-20,671
-67% -$37K
MF
1090
DELISTED
Missfresh Limited American Depositary Shares
MF
$12K ﹤0.01%
13,474
-10,305
-43% -$9.86K
ASNS
1091
DELISTED
ACTELIS NETWORKS INC
ASNS
$11K ﹤0.01%
+1,013
New +$19.2K
AVPTW
1092
DELISTED
AvePoint Inc Warrant
AVPTW
$11K ﹤0.01%
+11,205
New +$10.9K
BON
1093
Bon Natural Life
BON
$9.35M
$11K ﹤0.01%
107
-15
-12% -$2.15K
EDTK icon
1094
Skillful Craftsman
EDTK
$14.3M
$11K ﹤0.01%
10,554
-9,169
-46% -$10.8K
HSCS icon
1095
Heart Test Laboratories
HSCS
$7.99M
$11K ﹤0.01%
+256
New +$19.9K
IFBD icon
1096
Infobird
IFBD
$8.64M
$11K ﹤0.01%
+675
New +$56.8K
SXTP icon
1097
60 Degrees Pharmaceuticals
SXTP
$3M
$11K ﹤0.01%
+60
New +$24.9K
TENX icon
1098
Tenax Therapeutics
TENX
$60.6M
$11K ﹤0.01%
+460
New +$11.7K
ETWO.WS
1099
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$11K ﹤0.01%
+24,249
New +$12.2K
MMAT
1100
DELISTED
Meta Materials Inc. Common Stock
MMAT
$11K ﹤0.01%
523
+275
+111% +$6.02K

Similar funds

Virtu Financial's Q3 2023 Portfolio in Review

As of Q3 2023, Virtu Financial held 2,245 positions worth $1.01B, down 23% from $1.31B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Virtu Financial withdrew a net $271M in Q3 2023, closing 1,018 positions and reducing 205 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $115M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 18% of assets, up from 9.6% a quarter earlier, followed by Financials and Technology.

Against the trend, Virtu Financial opened a new position in Eli Lilly worth $8.58M.

  • Virtu Financial's largest Q3 2023 buy was Eli Lilly: 15,978 shares worth $8.58M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q3 2023, an estimated $23.8M increase.
  • Virtu Financial's biggest Q3 2023 reduction was Berkshire Hathaway Class B, cutting an estimated $49.6M.
  • Virtu Financial fully exited State Street SPDR S&P 500 ETF Trust in Q3 2023, selling an estimated $115M.
  • Virtu Financial's ten largest holdings make up 33% of its $1.01B portfolio in Q3 2023.
  • Virtu Financial opened 779 new positions and closed 1,018 in Q3 2023.
  • Virtu Financial's portfolio value fell 23% quarter-over-quarter to $1.01B.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.